Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development

Contributed by: Business Wire

Logo

Tags

Health

Health Technology

Genetics

Research

Science

Pharmaceutical

Biotechnology

Elegen

More Like This

Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology

PR Newswire associated0

Turn Biotechnologies' Expanded eTurna™ Delivery Platform Designed to Solve Delivery and Targeting Issues that Challenge Industry

PR Newswire associated0

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

CleanNA Enters the Molecular Diagnostics Market by Launching Its First CE-IVD Product

PR Newswire associated0

Lexogen launches Streamlined, Large-scale RNA-Seq Service for Blood Samples

PR Newswire associated0

Element Biosciences to Showcase Sequencing Innovations at the European Human Genetics Conference

PR Newswire associated0

Lexogen launches end-to-end solutions for FFPE Transcriptomics

Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling